Furthermore, luciferase assays in triple negative breast cancer cells confirmed the activity of an L1PA2-derived promoter, where the transposon was found to account for a significant proportion of promoter activity to the SYT1 gene35. The gene discussed is SYT1; the disease is triple-negative breast carcinoma.